[go: up one dir, main page]

MX2015003740A - Metodo para evaluar la reaccion de coagulacion sanguinea. - Google Patents

Metodo para evaluar la reaccion de coagulacion sanguinea.

Info

Publication number
MX2015003740A
MX2015003740A MX2015003740A MX2015003740A MX2015003740A MX 2015003740 A MX2015003740 A MX 2015003740A MX 2015003740 A MX2015003740 A MX 2015003740A MX 2015003740 A MX2015003740 A MX 2015003740A MX 2015003740 A MX2015003740 A MX 2015003740A
Authority
MX
Mexico
Prior art keywords
blood coagulation
activity
coagulation
coagulation reaction
blood
Prior art date
Application number
MX2015003740A
Other languages
English (en)
Other versions
MX358997B (es
Inventor
Tetsuhiro Soeda
Takehisa Kitazawa
Midori Shima
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of MX2015003740A publication Critical patent/MX2015003740A/es
Publication of MX358997B publication Critical patent/MX358997B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96452—Factor XI (3.4.21.27)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/224—Haemostasis or coagulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se estudiaron varios métodos para evaluar el efecto hemostático y varios reactivos de inicio de coagulación sanguínea para construir un método para evaluar la reacción de coagulación sanguínea mediada por una sustancia que tiene la actividad de sustituir el factor VIII de coagulación (FVIII). Como resultado, se descubrió que al usar un reactivo de inicio de coagulación que contiene el factor IX de coagulación, activado (FXIa9 y fosfolípidos, se puede evaluar el efecto de una sustancia que tiene la actividad de sustituir el factor VIII de coagulación (FVIII) en la reacción de coagulación sanguínea, usando la cantidad de trombina generada en la muestra de sangre como un indicador.
MX2015003740A 2012-09-28 2013-09-26 Metodo para evaluar la reaccion de coagulacion sanguinea. MX358997B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012217925 2012-09-28
PCT/JP2013/075978 WO2014050926A1 (ja) 2012-09-28 2013-09-26 血液凝固反応の評価方法

Publications (2)

Publication Number Publication Date
MX2015003740A true MX2015003740A (es) 2015-09-23
MX358997B MX358997B (es) 2018-09-12

Family

ID=50388321

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015003740A MX358997B (es) 2012-09-28 2013-09-26 Metodo para evaluar la reaccion de coagulacion sanguinea.

Country Status (13)

Country Link
US (1) US11078518B2 (es)
EP (1) EP2902787B1 (es)
JP (1) JP6284481B2 (es)
KR (1) KR102134305B1 (es)
CN (1) CN104937423B (es)
BR (1) BR112015006634B1 (es)
CA (1) CA2886326C (es)
ES (1) ES2668455T3 (es)
MX (1) MX358997B (es)
PL (1) PL2902787T3 (es)
RU (1) RU2683933C2 (es)
TW (1) TWI609083B (es)
WO (1) WO2014050926A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12013500974A1 (en) 2010-11-17 2013-07-08 Chugai Pharmaceutical Co Ltd Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
TWI701435B (zh) * 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定ｆｖｉｉｉ的反應性之方法
TWI700300B (zh) * 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
EP3287791B1 (en) * 2015-04-24 2025-02-19 Public University Corporation Nara Medical University Method for evaluating coagulation ability of blood specimen, and reagent, reagent kit and device to be used therein
UA126900C2 (uk) 2016-04-28 2023-02-22 Чугаі Сейяку Кабусікі Кайся Антитіловмісний препарат
JP7101351B2 (ja) 2016-04-28 2022-07-15 シスメックス株式会社 血液検体の分析方法、血液検体分析用試薬及び試薬キット、並びに血液検体分析装置
JPWO2019088143A1 (ja) 2017-11-01 2020-11-12 中外製薬株式会社 生物活性が低下した抗体バリアントおよびアイソフォーム
RU2699798C1 (ru) * 2019-05-22 2019-09-11 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Способ выявления дефицитов факторов свертывания крови методом тромбоэластометрии
JP6883899B1 (ja) * 2020-12-07 2021-06-09 株式会社血栓トランスレーショナルリサーチラボ 血液凝固検査試薬、および血液凝固検査方法
EP4644905A1 (en) 2022-12-28 2025-11-05 Sekisui Medical Co., Ltd. Method for analyzing blood clotting ability of blood sample
EP4644906A1 (en) 2022-12-28 2025-11-05 Sekisui Medical Co., Ltd. Method for analyzing blood coagulation capability of blood specimen

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP2746386B2 (ja) * 1988-09-07 1998-05-06 清水製薬株式会社 全血を用いた血液凝固能検査法
DK162233C (da) 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
WO1993012227A1 (en) 1991-12-17 1993-06-24 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JP2938569B2 (ja) 1990-08-29 1999-08-23 ジェンファーム インターナショナル，インコーポレイティド 異種免疫グロブリンを作る方法及びトランスジェニックマウス
JP3368279B2 (ja) * 1992-04-27 2003-01-20 ベックマン コールター，インコーポレイティド 血液凝固検定を行うためのテスト物品及び方法
EP0652950B1 (en) 1992-07-24 2007-12-19 Amgen Fremont Inc. Generation of xenogeneic antibodies
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
FR2707189B1 (fr) 1993-07-09 1995-10-13 Gradient Ass Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé.
KR100261941B1 (ko) 1994-07-13 2000-07-15 나가야마 오사무 사람의 인터루킨-8에 대한 재구성 사람항체
DE69637481T2 (de) 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
AT405692B (de) * 1997-03-27 1999-10-25 Immuno Ag Reagens zur bestimmung der aptt
TR200101541T2 (tr) 1998-04-03 2002-06-21 Chugai Seiyaku Kabushiki Kaisha İnsan doku faktörüne (TF) karşı insanlaştırılmış antikor.
CA2421447C (en) 2000-09-08 2012-05-08 Universitat Zurich Collections of repeat proteins comprising repeat modules
CA2418835A1 (en) 2000-10-16 2002-04-25 Phylos, Inc. Protein scaffolds for antibody mimics and other binding proteins
US20030157561A1 (en) 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
WO2005035753A1 (ja) * 2003-10-10 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 機能蛋白質を代替する二重特異性抗体
EP1675878A2 (en) 2003-10-24 2006-07-05 Avidia, Inc. Ldl receptor class a and egf domain monomers and multimers
DE102005008066A1 (de) * 2005-02-22 2006-08-24 Haemosys Gmbh Verfahren zur Bestimmung der Gesamtgerinnungsaktivität einer Blut- oder Plasmaprobe
CA2957144C (en) 2005-04-08 2020-06-02 Chugai Seiyaku Kabushiki Kaisha Antibody substituting for function of blood coagulation factor viii
CN101415445A (zh) * 2006-03-31 2009-04-22 巴克斯特国际公司 聚乙二醇化的因子ⅷ
NZ572050A (en) 2006-03-31 2011-09-30 Baxter Int Factor VIII conjugated to polyethylene glycol
PH12013500974A1 (en) 2010-11-17 2013-07-08 Chugai Pharmaceutical Co Ltd Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
BR112014003787A2 (pt) 2011-08-23 2020-10-27 Synapse B.V. inibidores termoestáveis de ativação do sistema de coagulação sanguínea por contato com superfícies estranhas

Also Published As

Publication number Publication date
RU2015115277A (ru) 2016-11-20
EP2902787A4 (en) 2016-03-23
BR112015006634B1 (pt) 2022-06-14
CN104937423A (zh) 2015-09-23
BR112015006634A2 (es) 2017-09-05
CA2886326A1 (en) 2014-04-03
HK1212443A1 (en) 2016-06-10
TW201418470A (zh) 2014-05-16
MX358997B (es) 2018-09-12
PL2902787T3 (pl) 2018-08-31
TWI609083B (zh) 2017-12-21
RU2683933C2 (ru) 2019-04-03
CA2886326C (en) 2021-11-02
JPWO2014050926A1 (ja) 2016-08-22
KR20150068406A (ko) 2015-06-19
WO2014050926A1 (ja) 2014-04-03
US20150240287A1 (en) 2015-08-27
CN104937423B (zh) 2017-05-24
ES2668455T3 (es) 2018-05-18
EP2902787B1 (en) 2018-03-28
EP2902787A1 (en) 2015-08-05
KR102134305B1 (ko) 2020-07-15
US11078518B2 (en) 2021-08-03
JP6284481B2 (ja) 2018-02-28

Similar Documents

Publication Publication Date Title
MX2015003740A (es) Metodo para evaluar la reaccion de coagulacion sanguinea.
AU2018260845A1 (en) Evaluation and treatment of bradykinin-mediated disorders
EA030186B9 (ru) Способ проведения количественных анализов
TW200942619A (en) Apparatus and method for electrochemical detection
WO2012103479A3 (en) Gas sorption analysis of unconventional rock samples
MX2015001939A (es) Composiciones y metodos para microcapsulas.
HK1210831A1 (en) Compositions and methods for detecting protease activity in biological systems
WO2013190071A3 (en) Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood
BR112015022322A2 (pt) sistemas e métodos para detecção de células com o uso de partículas de transdução projetadas
BR112016008970A2 (pt) Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
GB2517875A (en) Modified base detection with nanopore sequencing
IN2014DE01077A (es)
WO2012159021A3 (en) Portable hemostasis analyzer
GB2519906A (en) Methods and systems for detecting biological components
IS2809B (is) Blóðstorkumæling
BR112012024206A2 (pt) método e sistema para analisar uma amostra de sangue
MX371379B (es) Deteccion de la actividad de corte de una enzima.
EP4279920A3 (en) Blood testing system and method
MX2016002692A (es) Camara de muestreo con depurador que reacciona con sulfuro de hidrogeno.
GB201206977D0 (en) An enzyme detection device
MX2016012055A (es) Ensayos de proteinas glicosiladas.
WO2014058652A3 (en) Wash monitor and method of use
MX2015001961A (es) Metodos y sistemas para ensayos.
JP2015042652A5 (es)

Legal Events

Date Code Title Description
FG Grant or registration